BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
The article, which features an interview with BioLargo CEO Dennis Calvert and Director of Strategic Marketing and Business Development Tonya Chandler, does a deep dive on why the AEC is set to disrupt the PFAS treatment market.
Download your copy of the article here:
No comments:
Post a Comment